GILDER GAGNON HOWE & CO LLC – Stoke Therapeutics, Inc. Transaction History
GILDER GAGNON HOWE & CO LLC portfolio value:
$743,000
portfolio value
GILDER GAGNON HOWE & CO LLC quarter portfolio value change:
-2.80%
quarter
Stoke Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.76% | -445 shares | -27K | $12.84 | 57.86K |
| Q2 2022 | share | Decrease | -89.67% | -506.20K shares | -11.11M | $13.21 | 58.30K |
| Q1 2022 | share | Decrease | -47.36% | -507.92K shares | -13.84M | $21.05 | 564.51K |
| Q4 2021 | share | Decrease | -4.53% | -50.91K shares | -2.85M | $24.07 | 1.07M |
| Q3 2021 | share | Decrease | -9.84% | -122.60K shares | -13.36M | $25.44 | 1.12M |
| Q2 2021 | share | Decrease | -1.58% | -19.99K shares | -7.23M | $33.66 | 1.24M |
| Q1 2021 | share | Decrease | -13.93% | -204.89K shares | -41.92M | $38.84 | 1.26M |
| Q4 2020 | share | Decrease | -1.30% | -19.31K shares | 41.18M | $61.93 | 1.47M |
| Q3 2020 | share | Decrease | -5.06% | -79.41K shares | 12.50M | $33.49 | 1.49M |
| Q2 2020 | share | Decrease | -6.95% | -117.18K shares | -1.22M | $23.83 | 1.56M |
| Q1 2020 | share | Decrease | -7.67% | -140.14K shares | -13.11M | $22.9 | 1.68M |
| Q4 2019 | share | Decrease | -2.63% | -49.30K shares | 11.41M | $28.32 | 1.82M |
| Q3 2019 | share | Increase | +0.78% | 14.56K shares | -13.98M | $21.49 | 1.87M |
| Q2 2019 | share | Increase | 0.00% | 1.86M shares | 54.30M | $29.17 | 1.86M |